| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10d08a3a036d6828a1d14741c1da41b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4ca6a474c99ca6c3ab713cd857bdee0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-35 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-35 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c100d40fbcf0b857a3d0b8c90d246d07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50b1f6b8eb963c68b8e092ddeb5aea1d |
| publicationDate |
2009-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009129521-A2 |
| titleOfInvention |
Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization |
| abstract |
A number of peptide epitopes and fragments from three Mycobacterium tuberculosis ( Mtb ) cell wall proteins have been identified as early antigens that induce antibodies early during Mtb infection in humans. The proteins are Proline-Threonine Repetitive Protein (PTRP), PE-PGRS51, and LipC. These peptides, alone or in mixtures, or as parts of fusion polypeptides or peptide multimers, are useful as antigens for serological detection of early in infection by detecting the presence of early antibodies against these proteins, thereby permitting earlier diagnosis of Mtb infection than was heretofore possible by conventional means. The above peptides and other peptide-based compositions are also used as immunogens for inclusion in TB vaccines. Also provided are methods for early diagnosis of Mtb infection and for immunizing a subject to prevent or treat Mtb infections and tuberculosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106405107-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108885213-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012164088-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3048286-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102004155-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017144830-A1 |
| priorityDate |
2008-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |